Picture of Pharvaris NV logo

PHVS Pharvaris NV News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview

* Pharvaris NV  PHVS.OQ   PHVS.O  is expected to report
results on November 1 (estimated).
​* Refinitiv's mean analyst estimate for Pharvaris NV is for a
loss of 45 cents per share. 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Pharvaris NV is
$48​, about 62.5% above​ its last closing price of $18.00. ​​​
* Previous quarterly performance (using preferred earnings
measure in euros). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.39       -0.42      -0.94     Missed  -122
 Mar. 31 2021  -0.34       -0.38      -0.66     Missed  -72.5
 Dec. 31 2020  -1.14       -1.14      -2.18     Missed  -90.7​
 ​​            ​                                        ​
                                                        ​
 This summary was machine generated October 29 at 16:56 GMT.  All
figures in euros unless otherwise stated

Recent news on Pharvaris NV

See all news